Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amarin Corp ADR (AMRN)

Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Amarin Corporation Announces National Reimbursement Approval for VAZKEPA® in Italy to Reduce Cardiovascular Risk in High-Risk Patients

Italy's NHS approved VAZKEPA® for reimbursement, enhancing access for high-risk cardiovascular patients in Europe.Quiver AI SummaryAmarin Corporation has announced that the Italian National Health Service...

AMRN : 0.4600 (-1.18%)
Amarin Receives National Reimbursement for VAZKEPA® in Italy

AMRN : 0.4600 (-1.18%)
Amarin Corporation Appoints Peter Fishman as Chief Financial Officer

Amarin Corporation appoints Peter Fishman as Chief Financial Officer, effective immediately, to lead global finance operations.Quiver AI SummaryAmarin Corporation has appointed Peter Fishman as Chief Financial...

AMRN : 0.4600 (-1.18%)
Amarin Appoints Peter Fishman Chief Financial Officer

AMRN : 0.4600 (-1.18%)
Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA)...

AMRN : 0.4600 (-1.18%)
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates

Amarin Corporation plc AMRN reported an adjusted loss of 5 cents per share for the third quarter of 2024, which was in line with the Zacks Consensus Estimate. The company had reported breakeven earnings...

FOLD : 9.80 (+0.72%)
AMRN : 0.4600 (-1.18%)
ARDX : 4.82 (+2.77%)
ATNM : 1.2900 (+15.18%)
Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript

AMRN earnings call for the period ending September 30, 2024.

AMRN : 0.4600 (-1.18%)
Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update

AMRN : 0.4600 (-1.18%)
Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript

AMRN earnings call for the period ending June 30, 2024.

AMRN : 0.4600 (-1.18%)
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript

AMRN earnings call for the period ending March 31, 2024.

AMRN : 0.4600 (-1.18%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar